JPMorgan Chase & Co’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6M | Sell |
601,363
-1,381,300
| -70% | -$13.8M | ﹤0.01% | 2565 |
|
|
2025
Q1 | $11.8M | Sell |
1,982,663
-86,133
| -4% | -$514K | ﹤0.01% | 2057 |
|
|
2024
Q4 | $15.9M | Buy |
2,068,796
+1,601,477
| +343% | +$12.3M | ﹤0.01% | 1901 |
|
|
2024
Q3 | $4.77M | Buy |
467,319
+5,368
| +1% | +$54.8K | ﹤0.01% | 2673 |
|
|
2024
Q2 | $6.86M | Buy |
461,951
+444,193
| +2,501% | +$6.59M | ﹤0.01% | 2341 |
|
|
2024
Q1 | $242K | Sell |
17,758
-5,494
| -24% | -$74.9K | ﹤0.01% | 4362 |
|
|
2023
Q4 | $255K | Sell |
23,252
-449
| -2% | -$4.92K | ﹤0.01% | 4300 |
|
|
2023
Q3 | $260K | Buy |
23,701
+3,253
| +16% | +$35.6K | ﹤0.01% | 4081 |
|
|
2023
Q2 | $271K | Sell |
20,448
-505,709
| -96% | -$6.7M | ﹤0.01% | 4109 |
|
|
2023
Q1 | $7.16M | Sell |
526,157
-57,801
| -10% | -$787K | ﹤0.01% | 2225 |
|
|
2022
Q4 | $11.4M | Buy |
583,958
+41,053
| +8% | +$802K | ﹤0.01% | 1816 |
|
|
2022
Q3 | $10.3M | Sell |
542,905
-16,394
| -3% | -$312K | ﹤0.01% | 1847 |
|
|
2022
Q2 | $11.5M | Buy |
559,299
+332,625
| +147% | +$6.85M | ﹤0.01% | 1780 |
|
|
2022
Q1 | $7.3M | Buy |
226,674
+167,992
| +286% | +$5.41M | ﹤0.01% | 2286 |
|
|
2021
Q4 | $2.73M | Buy |
58,682
+44,131
| +303% | +$2.06M | ﹤0.01% | 3013 |
|
|
2021
Q3 | $393K | Buy |
14,551
+2,567
| +21% | +$69.3K | ﹤0.01% | 4083 |
|
|
2021
Q2 | $307K | Buy |
11,984
+2,058
| +21% | +$52.7K | ﹤0.01% | 4270 |
|
|
2021
Q1 | $339K | Buy |
9,926
+4,890
| +97% | +$167K | ﹤0.01% | 4236 |
|
|
2020
Q4 | $170K | Buy |
5,036
+1,052
| +26% | +$35.5K | ﹤0.01% | 4191 |
|
|
2020
Q3 | $96K | Buy |
+3,984
| New | +$96K | ﹤0.01% | 4064 |
|